Welcome to the 18th Malvern Diabetic Foot Conference.

Malvern Hills

Wednesday 13 – Friday 15 May 2020

The Malvern Diabetic Foot Conference is the longest standing international diabetic foot meeting held in the UK, biennially.

Want to attend?

To express interest, please click here


Abstracts Required:

Please ensure that the projects you have undertaken can be included in the Oral Abstracts Presentations session at the Conference by ensuring that these are received for consideration before Friday 11th March 2016.

Please see the Abstract page on this website for submission criteria.

The 2020 Conference will be the 18th meeting since its inception in 1986 and the event brings together experts on the diabetic foot from up to 30 countries, predominantly North America and Western Europe.

This three day conference is designed to bring together physicians, surgeons, podiatrists, orthotists and nursing staff with a common interest in diabetic foot problems. It is anticipated that the conference will improve our understanding of this problem which represents one of the main causes for in-patient treatment amongst the diabetic population.

An application for CPD approval will be submitted to the Federation of the Royal Colleges of Physicians of the United Kingdom.

The 17th Malvern Diabetic Foot Conference welcomed 300 speakers, sponsors and delegates, and we are expecting to replicate this success in 2020. In fact we have already had a great deal of interest from previous attendees and sponsors.

If you have any questions please do not hesitate to e-mail thechairmen@malverndiabeticfoot.org or call the Event Team on +44 (0)1491 419800.

Malvern Diabetic Foot Conference
At the Limits Limited
Holly Tree Barn
Hambleden
Henley-on-Thames
Oxfordshire
RG9 6NB

Please note, places for the Malvern Diabetic Foot Conference can ONLY be reserved via this website.
External sites such as ’10times’ are not affiliated to this event and places cannot be reserved via their website.

This meeting is supported by grants and sponsorship from the pharmaceutical and device industries.
See here for details.